Mayo clinic researchers have discovered a combination of drugs that seem to be effective at killing 70 percent of cancer cells that are resistant to chemotherapy. The drug was a combination of ixabepilone and sunitinib – two drug which had not previous been used together. This combination could be a good option for the treatment of late-stage ovarian cancer.
ThirdAge, by Emily Jacobson, 12/7/11
Additional coverage: Health Insurance News, Medical News Today, Xinhua, Medical Xpress
Tags: Cancer, Ovarian Cancer